Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Current Assets: 2019-2024

Historic Current Assets for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $41.0 million.

  • Eton Pharmaceuticals' Current Assets rose 142.02% to $72.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.0 million, marking a year-over-year increase of 142.02%. This contributed to the annual value of $41.0 million for FY2024, which is 52.84% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Current Assets of $41.0 million as of FY2024, which was up 52.84% from $26.8 million recorded in FY2023.
  • Over the past 5 years, Eton Pharmaceuticals' Current Assets peaked at $41.0 million during FY2024, and registered a low of $20.0 million during FY2022.
  • Over the past 3 years, Eton Pharmaceuticals' median Current Assets value was $26.8 million (recorded in 2023), while the average stood at $29.3 million.
  • Its Current Assets has fluctuated over the past 5 years, first spiked by 64.57% in 2020, then dropped by 15.25% in 2022.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Current Assets stood at $24.7 million in 2020, then fell by 4.44% to $23.6 million in 2021, then dropped by 15.25% to $20.0 million in 2022, then spiked by 34.17% to $26.8 million in 2023, then soared by 52.84% to $41.0 million in 2024.